Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ)
CNY 4.77
(-0.83%)
CNY 4.77
(-0.83%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 892.85 Million CNY | 25.02% |
| 2022 | 714.19 Million CNY | -21.17% |
| 2021 | 906.03 Million CNY | 50.58% |
| 2020 | 601.71 Million CNY | 420.11% |
| 2019 | 115.68 Million CNY | 32.98% |
| 2018 | 87 Million CNY | 0.0% |
| 2017 | - CNY | -100.0% |
| 2016 | 54 Million CNY | -60.12% |
| 2015 | 135.4 Million CNY | 0.0% |
| 2014 | - CNY | -100.0% |
| 2013 | 165.33 Thousand CNY | -44.88% |
| 2012 | 299.97 Thousand CNY | -92.11% |
| 2011 | 3.8 Million CNY | -79.12% |
| 2010 | 18.2 Million CNY | -53.57% |
| 2009 | 39.2 Million CNY | 317.02% |
| 2008 | 9.4 Million CNY | 0.0% |
| 2007 | 9.4 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 717.21 Million CNY | -6.23% |
| 2024 Q3 | 532.46 Million CNY | -25.57% |
| 2024 Q1 | 764.82 Million CNY | -14.34% |
| 2023 Q1 | 1.15 Billion CNY | 61.19% |
| 2023 Q4 | 892.85 Million CNY | -7.83% |
| 2023 FY | 892.85 Million CNY | 25.02% |
| 2023 Q2 | 1.08 Billion CNY | -6.07% |
| 2023 Q3 | 968.68 Million CNY | -10.42% |
| 2022 Q3 | 888.63 Million CNY | -7.67% |
| 2022 FY | 714.19 Million CNY | -21.17% |
| 2022 Q2 | 962.47 Million CNY | 22.14% |
| 2022 Q4 | 714.19 Million CNY | -19.63% |
| 2022 Q1 | 788.02 Million CNY | -13.02% |
| 2021 Q3 | 628.61 Million CNY | -5.65% |
| 2021 FY | 906.03 Million CNY | 50.58% |
| 2021 Q1 | 706.26 Million CNY | 17.38% |
| 2021 Q2 | 666.22 Million CNY | -5.67% |
| 2021 Q4 | 906.03 Million CNY | 44.13% |
| 2020 Q3 | 524 Million CNY | 28.12% |
| 2020 Q4 | 601.71 Million CNY | 14.83% |
| 2020 Q2 | 409 Million CNY | 63.6% |
| 2020 Q1 | 250 Million CNY | 116.1% |
| 2020 FY | 601.71 Million CNY | 420.11% |
| 2019 Q2 | 37 Million CNY | 0.0% |
| 2019 Q4 | 115.68 Million CNY | 131.38% |
| 2019 FY | 115.68 Million CNY | 32.98% |
| 2019 Q3 | 50 Million CNY | 35.14% |
| 2019 Q1 | 37 Million CNY | -57.47% |
| 2018 Q3 | 87 Million CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | 87 Million CNY | 0.0% |
| 2018 Q4 | 87 Million CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2017 Q3 | - CNY | -100.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | -100.0% |
| 2017 Q1 | 30 Million CNY | -44.44% |
| 2017 Q2 | 39 Million CNY | 30.0% |
| 2016 Q2 | 391 Million CNY | 240.0% |
| 2016 FY | 54 Million CNY | -60.12% |
| 2016 Q4 | 54 Million CNY | -82.41% |
| 2016 Q3 | 307 Million CNY | -21.48% |
| 2016 Q1 | 115 Million CNY | -15.07% |
| 2015 Q3 | 154.9 Million CNY | -15.22% |
| 2015 Q4 | 135.4 Million CNY | -12.59% |
| 2015 FY | 135.4 Million CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q2 | 182.7 Million CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 Q3 | - CNY | -100.0% |
| 2014 FY | - CNY | -100.0% |
| 2014 Q2 | 30 Million CNY | 17143.06% |
| 2014 Q1 | 173.98 Thousand CNY | 5.23% |
| 2013 Q2 | 20 Million CNY | 6235.91% |
| 2013 Q4 | 165.33 Thousand CNY | -99.86% |
| 2013 FY | 165.33 Thousand CNY | -44.88% |
| 2013 Q1 | 315.66 Thousand CNY | 5.23% |
| 2013 Q3 | 120 Million CNY | 500.0% |
| 2012 FY | 299.97 Thousand CNY | -92.11% |
| 2012 Q1 | 3.8 Million CNY | 0.0% |
| 2012 Q4 | 299.97 Thousand CNY | -92.11% |
| 2012 Q3 | 3.8 Million CNY | 0.0% |
| 2012 Q2 | 3.8 Million CNY | 0.0% |
| 2011 Q1 | 17.2 Million CNY | -5.49% |
| 2011 FY | 3.8 Million CNY | -79.12% |
| 2011 Q4 | 3.8 Million CNY | 0.0% |
| 2011 Q2 | - CNY | -100.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2010 Q4 | 18.2 Million CNY | 0.0% |
| 2010 Q2 | 37.6 Million CNY | 0.0% |
| 2010 FY | 18.2 Million CNY | -53.57% |
| 2009 FY | 39.2 Million CNY | 317.02% |
| 2008 FY | 9.4 Million CNY | 0.0% |
| 2007 FY | 9.4 Million CNY | 0.0% |